A phase I trial of BKM120 combined with vemurafenib in BRAFV600E/k mutant advanced melanoma.
Alain Patrick Algazi
Research Funding - Novartis
Christian Posch
No relevant relationships to disclose
Susana Ortiz-Urda
No relevant relationships to disclose
Alyson Cockerill
No relevant relationships to disclose
Pamela N. Munster
Research Funding - Novartis
Adil Daud
Research Funding - Novartis